A 40-year-old woman with breast cancer was referred for treatment of a large pericardial effusion. She had been treated with right mastectomy, chemotherapy, radiotherapy, and tamoxifen but developed bone metastases. Four months earlier the patient underwent percutaneous kyphoplasty of lumbar vertebral bodies, right iliac wing and sternal body while receiving leuprorelin, exemestan, and denosumab. Progressive dyspnoea developed over the last 4 weeks. Physical admission revealed elevated jugular venous pressure and 12-lead electrocardiogram low voltage. Chest radiograph showed enlarged cardiac silhouette with linear high-density opacities along the right cardiac border. Echocardiography showed abundant pericardial effusion associated with a hyperechogenic 2 cm structure along the right atrial free wall. Pericardial drainage found non-specific and non-haemorrhagic inflammatory liquid. Thoracoabdominal CT scan and cardiac magnetic resonance imaging displayed high-density opacities in perivertebral veins, inferior vena cava, right atrium, and pulmonary arteries. The patient is doing well at 4-month follow-up with colchicine therapy. Polymethylmethacrylate cement is increasingly used to treat percutaneously osteolytic metastases. Polymethylmethacrylate cement leakage in the venous system may however yield complications. Pulmonary embolism of cement has been reported to occur in up to 26% of patients. These emboli are usually small and clinically silent. Penetrating cement fragments within cardiac chambers rarely injure the right ventricle and tricuspid valve. In our case, pericardial space examination did not show cardiac perforation. The presence of cement along the thinned wall of the right atrium likely induced reactive inflammatory pericardial effusion. Of note chronic deposition of foreign materials within the venous system may promote thrombotic manifestations. 
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